Octreotide-Lar in Later-Stage Autosomal Dominant Polycystic Kidney Disease (ALADIN 2): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
PLoS Medicine - United States
doi 10.1371/journal.pmed.1002777
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
Public Library of Science (PLoS)